Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
tRNA methyltransferase subunit 11-2 pseudogene 1 (abbreviated as TRMT112P1) is a pseudogene in the human genome. Pseudogenes are genomic sequences that resemble functional genes but are typically nonfunctional due to mutations or lack of transcription. TRMT112P1 does not encode a functional protein and lacks known molecular or therapeutic relevance. It is not a therapeutic target, enzyme, receptor, or transporter. There is no evidence from available genetic databases or scientific literature that it has any disease role, interacts with drugs, or serves as a biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on tRNA methyltransferase subunit 11-2 pseudogene 1 (TRMT112P1).